Developer docs
API playgroundTry for free, no card

Search company profiles

Lamed

Full company profile

uuid000o8as

Namestring
Lamed
Legal namestring
Lamed Vertriebsgesellschaft mbH für medizinische Produkte
Websiteurl
lamed.de
Company typeenum
Private
Founded yearint
1990
Short descriptiontext

Lamed Vertriebsgesellschaft mbH für medizinische Produkte is a German medical technology company that distributes specialized vascular, endovascular, and cardiovascular devices—including biological patches, stent grafts, steerable introducers, and surgical tools—to hospitals and surgeons across the DACH region.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOberhaching, Germany
HQ citystring
Oberhaching
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vascular surgery devices, endovascular medical products, biological vascular patches, cardiovascular surgical tools, stent graft systems
Industry4 codes
PRIMARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAFAH
Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHADAL
Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Vascular & Cardiovascular Surgery Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Sale of medical technology products including endovascular products, patches, hemostasis products, catheters, and surgical tools to healthcare institutions

lamed.de
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Vascu-Guard®
Description

Acellular biological vascular patch with documented clinical experience of over 30 years for use in vascular and cardiac surgery.

lamed.de
+3 more records
Core offering1 text field

Lamed manufactures and distributes a focused portfolio of medical devices for vascular, cardiovascular, and endovascular surgery, including thoracic aortic stent graft systems (Ankura™ TAA), acellular biological vascular patches (Vascu-Guard®), steerable introducer sheaths (Fustar™), multi-access sheath systems (H.Q.S + X-Cath), and ancillary surgical tools such as intraluminal shunts, vessel occluders, vascular probes, vein strippers, and vessel loops. These products are sold to acute-care hospitals, specialty clinics, and vascular/cardiac surgeons performing endovascular, cardiac, and peripheral vascular procedures.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Up to 1.5L blood savings during 4-fenestration procedures using H.Q.S. and X-Cath combination
Product overview1 text field

Lamed is a medical technology company offering a comprehensive portfolio of medical devices for cardiovascular and vascular surgery. The product range spans endovascular products (stent grafts), biological patches, catheters and introducers, surgical tools, hemostatic products, meshes, and staple line reinforcement. Key products include the Ankura™ TAA Stent Graft System for thoracic aortic treatments, Vascu-Guard® biological patches with 30+ years of clinical use, Fustar™ steerable introducers with 0-160° deflection, and the H.Q.S. sheath system with X-Cath multi-access adapter. The company also provides surgical tools including Flo-Thru shunts, FloRester® vessel occluders, vascular probes, vein strippers, and vessel loops for various surgical applications. Products are distributed primarily in Germany and Europe.

Product and service9 records
1Ankura™ TAA Stent Graft System
CategoryEndovascular product
Description

Stent graft system specifically designed for endovascular treatment of thoracic aortic dissections, aneurysms, and similar diseases; also available as in-situ fenestration system set with FuThrough™ fenestration needle. For vascular and cardiac surgeons.

2Vascu-Guard®
CategoryPatch
Description

Acellular biological patch for wide use in vascular surgery with documented clinical experience of over 30 years and molecular stability through cross-linking for permanent performance. CE-certified under MDD. For vascular and cardiac surgeons.

3Fustar™
CategoryCatheter
Description

Steerable introducer sheath enabling precise positioning and placement of ASD/PFO occluders with tip deflection from 0–160°, combining delivery sheath and guiding catheter functions. For interventional cardiologists and vascular surgeons.

4H.Q.S Implant Sheath + X-Cath
CategoryCatheter
Description

H.Q.S is an introduction sheath for optimized access in EVAR, TEVAR, and TAVI procedures with hemostatic sealing; X-Cath is a 4-channel attachment adapter enabling up to four parallel accesses with a single device. For endovascular and cardiac surgeons.

5Flo-Thru
CategorySurgical tool
Description

Intraluminal shunt used in coronary bypass surgery on the beating heart (off-pump) to maintain blood flow during the procedure. For cardiac surgeons.

6FloRester®
CategorySurgical tool
Description

Atraumatic vessel occluders used in coronary surgery as well as peripheral bypass surgery to temporarily block blood flow. For cardiac and vascular surgeons.

7Vascular Probe
CategorySurgical tool
Description

Probe used in coronary surgery for exact localization of vascular stenosis, as well as for stenting vessels or holding the IMA during anastomosis. For cardiac and vascular surgeons.

8Vein Strippers
CategorySurgical tool
Description

Single-use instruments made from polyamide equipped with three easily exchangeable heads of various diameters for vein removal procedures. For vascular surgeons.

9Vessel-Loops
CategorySurgical tool
Description

Retraction loops made from medical-grade platinum-cured silicone for the cerclage of vessels, nerves, and tendons; X-ray impermeable with oval shape for atraumatic application. For vascular, cardiac, and general surgeons.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierParentTypeOthers
Description

Lamed is a member of the Translumina Group, a company network specializing in medical technology products.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lamed

Vascular & Cardiovascular Surgery Medical Deviceslamed.de

Lamed Vertriebsgesellschaft mbH für medizinische Produkte is a German medical technology company that distributes specialized vascular, endovascular, and cardiovascular devices—including biological patches, stent grafts, steerable introducers, and surgical tools—to hospitals and surgeons across the DACH region.

Lamed firmographics

Firmographics
Name
Lamed
Legal name
Lamed Vertriebsgesellschaft mbH für medizinische Produkte
Website
https://lamed.de
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
11–50 employees
Short description
Lamed Vertriebsgesellschaft mbH für medizinische Produkte is a German medical technology company that distributes specialized vascular, endovascular, and cardiovascular devices—including biological patches, stent grafts, steerable introducers, and surgical tools—to hospitals and surgeons across the DACH region.
Ownership category
akta.pro rank

Lamed industry classification

Industry
Product category
Vascular & Cardiovascular Surgery Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAFAH
Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHADAL
Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Vascular surgery devices
  • Endovascular medical products
  • Biological vascular patches
  • Cardiovascular surgical tools
  • Stent graft systems

Where Lamed is headquartered

Location

Headquarters

HQ city
Oberhaching
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Lamed business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Medical Device Sales: Sale of medical technology products including endovascular products, patches, hemostasis products, catheters, and surgical tools to healthcare institutions

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Lamed product offering

Product offering

Core offering

Lamed manufactures and distributes a focused portfolio of medical devices for vascular, cardiovascular, and endovascular surgery, including thoracic aortic stent graft systems (Ankura™ TAA), acellular biological vascular patches (Vascu-Guard®), steerable introducer sheaths (Fustar™), multi-access sheath systems (H.Q.S + X-Cath), and ancillary surgical tools such as intraluminal shunts, vessel occluders, vascular probes, vein strippers, and vessel loops. These products are sold to acute-care hospitals, specialty clinics, and vascular/cardiac surgeons performing endovascular, cardiac, and peripheral vascular procedures.

Product overview

Lamed is a medical technology company offering a comprehensive portfolio of medical devices for cardiovascular and vascular surgery. The product range spans endovascular products (stent grafts), biological patches, catheters and introducers, surgical tools, hemostatic products, meshes, and staple line reinforcement. Key products include the Ankura™ TAA Stent Graft System for thoracic aortic treatments, Vascu-Guard® biological patches with 30+ years of clinical use, Fustar™ steerable introducers with 0-160° deflection, and the H.Q.S. sheath system with X-Cath multi-access adapter. The company also provides surgical tools including Flo-Thru shunts, FloRester® vessel occluders, vascular probes, vein strippers, and vessel loops for various surgical applications. Products are distributed primarily in Germany and Europe.

Differentiator

Problem solved

Functional benefit

Brands

  • Vascu-Guard®: Acellular biological vascular patch with documented clinical experience of over 30 years for use in vascular and cardiac surgery.
  • Fustar™
  • H.Q.S + X-Cath
  • Ankura™ TAA

Products and services

  • Ankura™ TAA Stent Graft System Stent graft system specifically designed for endovascular treatment of thoracic aortic dissections, aneurysms, and similar diseases; also available as in-situ fenestration system set with FuThrough™ fenestration needle. For vascular and cardiac surgeons.
  • Vascu-Guard® Acellular biological patch for wide use in vascular surgery with documented clinical experience of over 30 years and molecular stability through cross-linking for permanent performance. CE-certified under MDD. For vascular and cardiac surgeons.
  • Fustar™ Steerable introducer sheath enabling precise positioning and placement of ASD/PFO occluders with tip deflection from 0–160°, combining delivery sheath and guiding catheter functions. For interventional cardiologists and vascular surgeons.
  • H.Q.S Implant Sheath + X-Cath H.Q.S is an introduction sheath for optimized access in EVAR, TEVAR, and TAVI procedures with hemostatic sealing; X-Cath is a 4-channel attachment adapter enabling up to four parallel accesses with a single device. For endovascular and cardiac surgeons.
  • Flo-Thru Intraluminal shunt used in coronary bypass surgery on the beating heart (off-pump) to maintain blood flow during the procedure. For cardiac surgeons.
  • FloRester® Atraumatic vessel occluders used in coronary surgery as well as peripheral bypass surgery to temporarily block blood flow. For cardiac and vascular surgeons.
  • Vascular Probe Probe used in coronary surgery for exact localization of vascular stenosis, as well as for stenting vessels or holding the IMA during anastomosis. For cardiac and vascular surgeons.
  • Vein Strippers Single-use instruments made from polyamide equipped with three easily exchangeable heads of various diameters for vein removal procedures. For vascular surgeons.
  • Vessel-Loops Retraction loops made from medical-grade platinum-cured silicone for the cerclage of vessels, nerves, and tendons; X-ray impermeable with oval shape for atraumatic application. For vascular, cardiac, and general surgeons.

Quantifiable outcome

  • Up to 1.5L blood savings during 4-fenestration procedures using H.Q.S. and X-Cath combination

Companies that use Lamed

Customer profile

Segments2 records

Ideal customer profiles1 record

Lamed technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Lamed partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Translumina GroupparentOthersLamed is a member of the Translumina Group, a company network specializing in medical technology products.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Lamed competitors and assessment

Company assessment

Market position

Strengths4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Lamed social profiles

Digital presence

Lamed compliance and trust

Trust signal

Compliance1 record

Lamed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lamed leadership team

Management profile

Number of profiles

Profiles1 record

Lamed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lamed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lamed

What does Lamed do?

Lamed manufactures and distributes a focused portfolio of medical devices for vascular, cardiovascular, and endovascular surgery, including thoracic aortic stent graft systems (Ankura™ TAA), acellular biological vascular patches (Vascu-Guard®), steerable introducer sheaths (Fustar™), multi-access sheath systems (H.Q.S + X-Cath), and ancillary surgical tools such as intraluminal shunts, vessel occluders, vascular probes, vein strippers, and vessel loops. These products are sold to acute-care hospitals, specialty clinics, and vascular/cardiac surgeons performing endovascular, cardiac, and peripheral vascular procedures.

Is Lamed a public or private company?

Lamed is a private company. It is classified as corporate owned and is currently operating.

When was Lamed founded?

Lamed was founded in 1990. It employs 11 to 50 people.

Where is Lamed based?

Lamed is headquartered in Oberhaching, Germany, in the Europe region.

How does Lamed make money?

One revenue line is on record: medical Device Sales.

Does Lamed have an API?

No public API is recorded for Lamed.

What industry is Lamed in?

Lamed's product category is Vascular & Cardiovascular Surgery Medical Devices. Its primary akta.pro industry code is HLAHAFAK, Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems), with a secondary code of HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTranslumina bolsters its German presence with acquisition of Lamed GmbHTranslumina, a global interventional cardiovascular medical devices company, has acquired Munich-based Lamed GmbH to strengthen its presence in the German market. Lamed operates as a market access platform for vascular and cardiovascular products, covering over 1,000 hospitals through its group purchasing organization network in Germany, which is the largest interventional cardiology market in Europe. Translumina intends to leverage Lamed's platform and ecosystem relationships to introduce its portfolio of owned and partnered products across the German market.PR NewswireTranslumina stärkt seine deutsche Präsenz durch die Übernahme der Lamed GmbHTranslumina has acquired Lamed GmbH, a Munich-based market access platform for vascular and cardiovascular products, to strengthen its presence in the German medical device market. The acquisition provides Translumina with access to Lamed's network covering over 1,000 hospitals through a Group Purchasing Organization (GPO), facilitating the introduction of its product portfolio in Europe's largest interventional cardiology market.PR NewswireTranslumina renforce sa présence en Allemagne avec l'acquisition de Lamed GmbHTranslumina, a global leader in interventional cardiovascular medical devices, has acquired Lamed GmbH, a Munich-based market access platform for vascular and cardiovascular products. Founded in 1989, Lamed covers over 1,000 hospitals through its group purchasing organization (GPO) network in Germany, which is the largest interventional cardiology market in Europe. Translumina intends to leverage this platform to introduce its own and partnered product portfolio into the German market, strengthening its presence in the European medical devices sector.PR NewswireTranslumina refuerza su presencia en Alemania con la adquisición de Lamed GmbHTranslumina, a global cardiovascular medical device company, acquired Munich-based Lamed GmbH on June 8, 2023. Lamed operates a market access platform covering over 1,000 hospitals across Germany—the largest interventional cardiology market in Europe—giving Translumina significant entry into the market through an exclusive distribution network for differentiated vascular and cardiovascular products. Everstone Capital, the investor in Translumina, views this as positioning for accelerated growth in the peripheral vascular and interventional surgery sector in Germany.PR NewswireTranslumina refuerza su presencia en Alemania con la adquisición de Lamed GmbHTranslumina, a global leader in cardiovascular interventional medical devices, announced the acquisition of Lamed GmbH, a Munich-based market access platform for vascular and cardiovascular products established in 1989. The deal provides Translumina access to over 1,000 hospitals through Lamed's GPO network in Germany, the largest interventional cardiology market in Europe, enabling the company to introduce its own and partner products into this key market. Everstone Capital, Translumina's private equity backer, highlighted the acquisition as positioning the company for accelerated growth in Germany's vascular and interventional surgery sector.PR NewswireTranslumina reforça sua presença na Alemanha com a aquisição da Lamed GmbHTranslumina, a global interventional cardiovascular medical devices company, announced the acquisition of Lamed GmbH, a Munich-based platform for vascular and cardiovascular products. Founded in 1989, Lamed covers more than 1,000 hospitals through its GPO network in Germany, the largest interventional cardiology market in Europe. The acquisition is positioned as strategically important, granting Translumina significant access to the German vascular and cardiovascular markets and enabling it to introduce its own and partner product portfolios through Lamed's established network.Ani NewsTranslumina bolsters its German presence with acquisition of Lamed GmbHTranslumina announced the acquisition of Munich-based Lamed GmbH on June 7, strengthening its presence in Germany's cardiovascular medical device market. This strategic acquisition aims to enhance Translumina's ability to provide a comprehensive cardiovascular portfolio across key global markets, leveraging Lamed's established relationships in over 1,000 hospitals.PR NewswireTranslumina bolsters its German presence with acquisition of Lamed GmbHTranslumina announced the acquisition of Munich-based Lamed GmbH to expand its presence in the German cardiovascular market. This strategic move allows Translumina to leverage Lamed's extensive network covering over 1,000 hospitals through a Group Purchasing Organization (GPO) to introduce its product portfolio in Europe's largest interventional cardiology market.GlobeNewswireLamed to Sell Fish-Skin Wound-Treatment Product in Germany, Austria and SwitzerlandLamed GmbH will market and distribute Kerecis fish-skin wound-treatment product in Germany, Austria, and Switzerland. Germany has four million chronic wounds annually, with 30,000 requiring amputation and treatment costs of about six billion euros. The company expects demand to rise as diabetes prevalence increases.